[1] Hadji P, Blettner M, Harbeck N, et al. The Patient's Anastrozole Compliance to Therapy (PACT) Program:a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer[J]. Ann Oncol, 2013, 24(6):1505-1512. [2] Simon R, Latreille J, Matte C, et al. Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up[J]. Can J Surg, 2014, 57(1):26-32. [3] Morisky, Donald E, Ang A, et al. Predictive validity of a medication adherence measure in an outpatient setting[J].J Clin Hypertens, 2008, 10(5):348-354. [4] Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6):1471-1474. [5] Ursem CJ, Bosworth HB, Shelby RA, et al. Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income[J]. J Womens Health, 2015, 24(5):403-408. [6] Osborne CK. Tamoxifen in the treatment of breast cancer[J]. New Engl J Med, 1998, 339(22):1609-1618. [7] Ma CX, Reinert T, Chmielewska I, et al. Mechanisms of aromatase inhibitor resistance[J]. Nat Rev Cancer, 2015, 15(5):261-275. [8] Breast International Group (BIG) 1-98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer[J]. New Engl J Med, 2005, 353(26):2747-2757. [9] Early Breast Cancer Trialists' Collaborative Group. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials[J]. Lancet, 2015, 386(10001):1341-1352. [10] Fleming CA, Heneghan HM, O’Brien D, et al. Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy[J]. Br J Surg, 2018, 105(9):1098-1106. [11] Kimmick G, Anderson R, Camacho F, et al. Adjuvant hormonal therapy use among insured, low-income women with breast cancer[J]. J Clin Oncol, 2009, 27(21):3445-3451. [12] Lundgren C, Lindman H, Rolander B, et al. Good adherence to adjuvant endocrine therapy in early breast cancer-a population-based study based on the Swedish Prescribed Drug Register[J]. Acta Oncologica, 2018, 57(7):935-940. [13] Burgess C, Cornelius V, Love S, et al. Depression and anxiety in women with early breast cancer:five year observational cohort study[J]. BMJ, 2005, 330(7493):702. [14] 江艳, 陈曦, 贺健梅. 心理精神因素对艾滋病患者抗病毒治疗依从性影响研究进展[J]. 实用预防医学, 2016,23(1):129-132. [15] 张海瑞, 王志玲, 门可. 强化健康教育对社区老年糖尿病患者生活方式的影响研究[J]. 实用预防医学, 2019,26(10):1159-1161.